BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, ...
Verywell Health on MSN
Can an armpit lump be a symptom of breast cancer?
Medically reviewed by Doru Paul, MD Key Takeaways An armpit lump, also called axillary lump, can be a symptom of breast ...
Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant chemotherapy, ...
Axillary lymph node involvement is the best prognostic factor for breast cancer survival. Staging breast cancers by axillary dissection remains standard management and is part of the UK national ...
One of the potential side effects of the Covid-19 vaccine is axillary lymphadenopathy. (Photo by Daniel Garzon Herazo/NurPhoto via Getty Images) There’s a potential side effect with the Covid-19 ...
Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...
There is no consensus method for the histological analysis of axillary sentinel nodes (SN). This study aimed to (1) assess the rate of occult metastases in SN using large serial sectioning and ...
Minor reactions following Covid-19 vaccination are common, and can include fever, chills, fatigue, body aches, a bump or redness at the injection site, or lymph node swelling. All of these are signs ...
Patients with lymph node-positive breast cancer may still avoid extensive axillary surgery if they have clear nodes after systemic therapy, data from a prospective registry showed. Patients with clear ...
Verywell Health on MSN
16 possible reasons why your armpit is hurting
Medically reviewed by Theresa Marko, PT, DPT, MS Key Takeaways Armpit pain can come from injuries, infections, or swollen lymph nodes. To diagnose armpit pain, doctors may use lab tests, physical ...
Radiation has been a staple of breast cancer treatment for decades, but a new study is casting doubt on whether it is ...
AstraZeneca and Daiichi Sankyo’s Enhertu's breakthrough therapy designation as a post-neoadjuvant treatment option for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results